Search research articles
Contact Us
Filters
Showing results (321-330 of 395) with videos related to
Page
of 40
Sort By:
Clinical and Experimental Rheumatology
|
June 5, 2025
Fibromyalgia: one year in review 2025
Cristina Iannuccelli, Martina Favretti, Giulio Dolcini, et al.
Clinical and Experimental Rheumatology
|
September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy
Roberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
Clinical and Experimental Rheumatology
|
May 11, 2019
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients
Ennio Giulio Favalli, Fabrizio Conti, Carlo Selmi, et al.
Journal of Clinical Medicine
|
June 26, 2025
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients
Fabiola Atzeni, Cinzia Rotondo, Cesare Siragusano, et al.
Journal of Clinical Medicine
|
April 28, 2023
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium"
Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, et al.
European Journal of Internal Medicine
|
July 12, 2022
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
Gian Luca Erre, Fabio Cacciapaglia, Garifallia Sakellariou, et al.
Arthritis Care & Research
|
November 12, 2015
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection
Melissa Padovan, Matteo Filippini, Angela Tincani, et al.
European Journal of Internal Medicine
|
October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
Fabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Frontiers in Medicine
|
March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
Andreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Clinical and Experimental Rheumatology
|
June 22, 2026
Pathogenetic and clinical aspects of fibromyalgia: one year in review 2026
Cristina Iannuccelli, Martina Favretti, Benedetta Bianchi, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 395) with videos related to
Sort By:
Page
of 40
Clinical and Experimental Rheumatology
|
June 5, 2025
Fibromyalgia: one year in review 2025
Cristina Iannuccelli, Martina Favretti, Giulio Dolcini, et al.
Clinical and Experimental Rheumatology
|
September 13, 2011
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy
Roberto Caporali, Fabrizio Conti, Stefano Alivernini, et al.
Clinical and Experimental Rheumatology
|
May 11, 2019
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients
Ennio Giulio Favalli, Fabrizio Conti, Carlo Selmi, et al.
Journal of Clinical Medicine
|
June 26, 2025
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients
Fabiola Atzeni, Cinzia Rotondo, Cesare Siragusano, et al.
Journal of Clinical Medicine
|
April 28, 2023
Rheumatoid Arthritis from Easy to Complex Disease: From the "2022 GISEA International Symposium"
Simone Perniola, Maria Sole Chimenti, Francesca Romana Spinelli, et al.
European Journal of Internal Medicine
|
July 12, 2022
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
Gian Luca Erre, Fabio Cacciapaglia, Garifallia Sakellariou, et al.
Arthritis Care & Research
|
November 12, 2015
Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection
Melissa Padovan, Matteo Filippini, Angela Tincani, et al.
European Journal of Internal Medicine
|
October 18, 2021
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
Fabio Cacciapaglia, Francesca Romana Spinelli, Matteo Piga, et al.
Frontiers in Medicine
|
March 26, 2024
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
Andreina Manfredi, Marco Fornaro, Chiara Bazzani, et al.
Clinical and Experimental Rheumatology
|
June 22, 2026
Pathogenetic and clinical aspects of fibromyalgia: one year in review 2026
Cristina Iannuccelli, Martina Favretti, Benedetta Bianchi, et al.
Page
of 40